The uniqueness of AlaRS and its human disease connections. Issue 11 (2nd November 2021)

• Record Type: Journal Article
• Authors: Zhang, Han; Yang, Xiang-Lei; Sun, Litao
• Is Part Of: RNA biology. Volume 18:Issue 11(2021)
• Page Start: 1501
• Page End: 1511
• Publication Date: 2021-11-02
• Subjects: Alanyl-tRNA synthetase -- aminoacyl-tRNA synthetase -- mutation -- neurodegeneration; RNA -- Periodicals; Molecular biology -- Periodicals; Molecular biology; RNA; Periodicals; 572.8805
• DOI: 10.1080/15476286.2020.1861803
• Languages: English
• ISSNs: 1547-6286

Abstract

ABSTRACT: Among the 20 cytoplasmic aminoacyl-tRNA synthetases (aaRSs), alanyl-tRNA synthetase (AlaRS) has unique features. AlaRS is the only aaRS that exclusively recognizes a single G3:U70 wobble base pair in the acceptor stem of tRNA, which serves as the identity element for both the synthetic and the proofreading activities of the synthetase. The recognition is relaxed during evolution and eukaryotic AlaRS can mis-aminoacylate noncognate tRNAs with a G4:U69 base pair seemingly as a deliberate gain of function for unknown reasons. Unlike other class II aaRSs, dimerization of AlaRS is not necessarily required for aminoacylation possibly due to functional compensations from the C-terminal domain (C-Ala). In contrast to other 19 cytoplasmic aaRSs that append additional domains or motifs to acquire new functions during evolution, the functional expansion of AlaRS is likely achieved through transformations of the existing C-Ala. Given both essential canonical and diverse non-canonical roles of AlaRS, dysfunction of AlaRS leads to neurodegenerative disorders in human and various pathological phenotypes in mouse models. In this review, the uniqueness of AlaRS in both physiological and pathological events is systematically discussed, with a particular focus on its novel functions gained in evolution.